Skip to content
10-Q

Quarterly Report

SYRA HEALTH CORP. SYRA

0001493152-26-021773

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 11.34M sh
Shares Diluted Q1 2026 · Mar 31, 2026 12.78M sh
Shares Diluted Q1 2026 · Mar 31, 2025 11.59M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 $1.36M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $158.23K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $2.92M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.61M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.36M
Stockholders Equity Q1 2026 · Dec 31, 2025 $2.1M
Stockholders Equity Q1 2026 · Mar 31, 2025 $2.46M
Stockholders Equity Q1 2026 · Dec 31, 2024 $2.88M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.58M
Current Liabilities Q1 2026 · Dec 31, 2025 $674.74K
Total Liabilities Q1 2026 · Mar 31, 2026 $1.58M
Total Liabilities Q1 2026 · Dec 31, 2025 $674.74K
Current Assets Q1 2026 · Mar 31, 2026 $3.93M
Current Assets Q1 2026 · Dec 31, 2025 $2.74M
Total Assets Q1 2026 · Mar 31, 2026 $3.94M
Total Assets Q1 2026 · Dec 31, 2025 $2.77M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.02
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.04
Eps Basic Q1 2026 · Mar 31, 2026 $0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.04
Sga Expense Q1 2026 · Mar 31, 2026 $213.05K
Sga Expense Q1 2026 · Mar 31, 2025 $287.29K
Rd Expense Q1 2026 · Mar 31, 2026 $6.92K
Rd Expense Q1 2026 · Mar 31, 2025 $37.17K
Net Income Q1 2026 · Mar 31, 2026 $240.98K
Net Income Q1 2026 · Mar 31, 2025 −$472.27K
Operating Income Q1 2026 · Mar 31, 2026 $190.98K
Operating Income Q1 2026 · Mar 31, 2025 −$473.33K
Gross Profit Q1 2026 · Mar 31, 2026 $971.26K
Gross Profit Q1 2026 · Mar 31, 2025 $589.16K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.3M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.27M
Revenue Q1 2026 · Mar 31, 2026 $2.27M
Revenue Q1 2026 · Mar 31, 2025 $1.86M